Aldosterone: Villain or bystander?DLUHY, Robert G; WILLIAMS, Gordon H.The New England journal of medicine. 2004, Vol 351, Num 1, pp 8-10, issn 0028-4793, 3 p.Article

Aldosterone receptor antagonists for hypertension: What do they offer?LIEW, Danny; KRUM, Henry.Drugs (Basel). 2003, Vol 63, Num 19, pp 1963-1972, issn 0012-6667, 10 p.Article

Mineralocorticoid Receptor Blocker Eplerenone Reduces Pain Behaviors In Vivo and Decreases Excitability in Small-diameter Sensory Neurons from Local Inflamed Dorsal Root Ganglia In VitroFEI DONG; WENRUI XIE; STRONG, Judith A et al.Anesthesiology (Philadelphia). 2012, Vol 117, Num 5, pp 1102-1112, issn 0003-3022, 11 p.Article

Dosage des précurseurs de l'aldostérone: intérêt diagnostique et physiopathologique = Assay for aldosterone precursors: a tool for clinical diagnosis and adrenal physiopathologyLEGRAND, J.-C; AUPETIT, B.Bulletin de l'Académie nationale de médecine. 1989, Vol 173, Num 6, pp 735-741, issn 0001-4079, 7 p.Article

Effect of octreotide on aldosterone secretion in humansDE KLERK SOMMERS; SNYMAN, J. R; VAN WYK, M et al.Medical science research. 1992, Vol 20, Num 20, issn 0269-8951, p. 733Article

Role of intestinal bacteria in the metabolism of aldosterone in manMIYAMORI, I; KOSHIDA, H; MATSUBARA, T et al.Hormone research. 1988, Vol 29, Num 4, pp 147-150, issn 0301-0163Article

Aldosterone blockade in cardiovascular diseaseSTRUTHERS, Allan D.Heart (London 1996). 2004, Vol 90, Num 10, pp 1229-1234, issn 1355-6037, 6 p.Article

Système rénine-angiotensine-aldostérone et insuffisance cardiaque conséquences thérapeutiques : Actualités sur le Système Rénine-Angiotensine-Aldostérone = Renin-angiotensin-aldosterone system and heart failure pathophysiologic and therapeutic aspectsCASTAIGNE, A; BENACERAFF, S.Thérapie (Paris). 1998, Vol 53, Num 3, pp 285-289, issn 0040-5957Article

Low molecular weight heparins and hypoaldosteronismLEVESQUE, H; VERDIER, S; CAILLEUX, N et al.BMJ. British medical journal (International ed.). 1990, Vol 300, Num 6737, pp 1437-1438, issn 0959-8146Article

Plasma levels of aldosterone precursors (including the 18-hydroxylated compounds in this synthesis pathway) : a tool for the analysis of adrenal disorders ?AUPETIT-FAISANT, B.Hormone research. 1990, Vol 34, Num 3-4, pp 142-150, issn 0301-0163, 9 p.Conference Paper

Determination of an aldosterone antagonist in urine by high-performance liquid chromatography using automated column switchingTIMM, U; SANER, A.Journal of chromatography. 1986, Vol 378, Num 1, pp 25-34, issn 0021-9673Article

Le taux de l'aldostérone plasmatique chez le nouveau-né à terme et chez la mèreCULLU, F; HATEMI, S; HATEMI, H et al.Médecine et hygiène. 1990, Vol 48, Num 1829, pp 488-489, issn 0025-6749Article

Stereoselective synthesis of the two major metabolites of spironolactone, 3α- and 3β-hydroxy-7α-methylthio-17α-pregn-4-ene-21,17-carbolactoneGUO LI; YAN ZHANG.Steroids. 2007, Vol 72, Num 6-7, pp 569-572, issn 0039-128X, 4 p.Article

The renin-angiotensin-aldosterone system in normal 85-year-old peopleSKOTT, P; INGERSLEV, J; DAMKJAER NIELSEN, M et al.Scandinavian journal of clinical & laboratory investigation. 1987, Vol 47, Num 1, pp 69-74, issn 0036-5513Article

A diastereoselective synthesis of 7α-nitromethyl steroid derivative and its use for an efficient synthesis of eplerenoneBIN ZHANG; HONGLI CHEN; HUANYU TANG et al.Steroids. 2012, Vol 77, Num 11, pp 1086-1091, issn 0039-128X, 6 p.Article

Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once AppearedMARTINEZ, Felipe A.Cardiovascular drugs and therapy. 2010, Vol 24, Num 4, pp 345-350, issn 0920-3206, 6 p.Conference Paper

Heart failure, platelet activation and inhibition of the renin-angiotensin-aldosterone systemBAUERSACHS, J; SCHÄFER, A.Archives des maladies du coeur et des vaisseaux. 2004, Vol 97, Num 9, pp 889-893, issn 0003-9683, 5 p.Article

Aldosterone in congestive heart failureWEBER, Karl T.The New England journal of medicine. 2001, Vol 345, Num 23, pp 1689-1697, issn 0028-4793Article

Effects of nifedipine treatment on the renin-angiotensin-aldosterone axisFIAD, T. M; CUNNINGHAM, S. K; HAYES, F. J et al.The Journal of clinical endocrinology and metabolism. 1997, Vol 82, Num 2, pp 457-460, issn 0021-972XArticle

Effects of atrial natriuretic factor on the renin-aldosterone system : in vivo and in vitro studiesBÄHR, V; SANDER-BÄHR, C; ARDEVOL, R et al.Journal of steroid biochemistry and molecular biology. 1993, Vol 45, Num 1-3, pp 173-178, issn 0960-0760Conference Paper

Atrial natriuretic peptide administration to normal and salt depleted rats ― Effects on digoxin-like immunoreactive factor, aldosterone, ACTH, and renal functionSHILO, L; POMERANZ, A; RATHAUS, M et al.Life sciences (1973). 1988, Vol 42, Num 19, pp 1855-1859, issn 0024-3205Article

Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat HospitalizationsROGERS, Jennifer K; MCMURRAY, John J. V; POCOCK, Stuart J et al.Circulation (New York, N.Y.). 2012, Vol 126, Num 19, pp 2317-2323, issn 0009-7322, 7 p.Article

Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertensionSATO, A; FUKUDA, S.Journal of human hypertension. 2010, Vol 24, Num 6, pp 387-394, issn 0950-9240, 8 p.Article

The effect of spironolactone on sweat and urinary sodium excretion during exercise in humansLEE, Nanette V. L; MILLER, Paul W; BUONO, Michael J et al.Clinical physiology and functional imaging (Print). 2010, Vol 30, Num 1, pp 13-16, issn 1475-0961, 4 p.Article

La renaissance de l'aldostérone et de ses antagonistes : Hypertension = The revival of aldosterone and its antagonistsBURNIE, M.Médecine et hygiène. 2002, Vol 60, Num 2397, pp 1251-1254, issn 0025-6749Article